tyrosine and pf 00299804

tyrosine has been researched along with pf 00299804 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bergonzini, C; Giovannetti, E; Leonetti, A; Peters, GJ; Tiseo, M	1

Other Studies

1 other study(ies) available for tyrosine and pf 00299804

Article	Year
Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer? Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:11 Topics: Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolinones; Tyrosine	2020

Article

Year

Is there a role for dacomitinib, a second-generation irreversible inhibitor of the epidermal-growth factor receptor tyrosine kinase, in advanced non-small cell lung cancer?

Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:11

Topics: Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolinones; Tyrosine

2020